Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert L Findling

Showing results (91-100 of 443) with videos related to

Pageof 45
Sort By:
Journal of Child and Adolescent Psychopharmacology|February 24, 2004
Employing parent, teacher, and youth self-report checklists in identifying pediatric bipolar spectrum disorders: an examination of diagnostic accuracy and clinical utilityShoshana Y Kahana, Eric A Youngstrom, Robert L Findling, et al.
The American Journal of Psychiatry|April 2, 2004
Long-term, open-label study of risperidone in children with severe disruptive behaviors and below-average IQRobert L Findling, Michael G Aman, Marielle Eerdekens, et al.
Development and Psychopathology|October 27, 2006
Diagnostic and measurement issues in the assessment of pediatric bipolar disorder: implications for understanding mood disorder across the life cycleEric Youngstrom, Oren Meyers, Jennifer Kogos Youngstrom, et al.
CNS Spectrums|July 14, 2010
A randomized, double-blind, multicenter, parallel-group, placebo-controlled, dose-optimization study of the methylphenidate transdermal system for the treatment of ADHD in adolescentsRobert L Findling, John Turnbow, John Burnside, et al.
Journal of Child and Adolescent Psychopharmacology|June 24, 2014
Efficacy and safety of extended-release quetiapine fumarate in youth with bipolar depression: an 8 week, double-blind, placebo-controlled trialRobert L Findling, Sanjeev Pathak, Willie R Earley, et al.
Biological Psychiatry|October 24, 2006
Comparing the effects of sampling designs on the diagnostic accuracy of eight promising screening algorithms for pediatric bipolar disorderEric Youngstrom, Oren Meyers, Jennifer Kogos Youngstrom, et al.
Paediatric Drugs|April 11, 2018
A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Vilazodone in Adolescents with Major Depressive DisorderSuresh Durgam, Changzheng Chen, Raffaele Migliore, et al.
The American Journal of Psychiatry|August 3, 2002
Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligenceMichael G Aman, Goedele De Smedt, Albert Derivan, et al.
Clinical Neuropharmacology|May 8, 2012
Atomoxetine once daily for 24 weeks in adults with attention-deficit/hyperactivity disorder (ADHD): impact of treatment on family functioningLinda Wietecha, Joel Young, Dustin Ruff, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|July 22, 2005
Pharmacological management of agitation and aggression in an adolescent with autismChristopher J Kratochvil, Robert L Findling, Christopher J McDougle, et al.
Pageof 45

Showing results (91-100 of 443) with videos related to

Sort By:
Pageof 45
Journal of Child and Adolescent Psychopharmacology|February 24, 2004
Employing parent, teacher, and youth self-report checklists in identifying pediatric bipolar spectrum disorders: an examination of diagnostic accuracy and clinical utilityShoshana Y Kahana, Eric A Youngstrom, Robert L Findling, et al.
The American Journal of Psychiatry|April 2, 2004
Long-term, open-label study of risperidone in children with severe disruptive behaviors and below-average IQRobert L Findling, Michael G Aman, Marielle Eerdekens, et al.
Development and Psychopathology|October 27, 2006
Diagnostic and measurement issues in the assessment of pediatric bipolar disorder: implications for understanding mood disorder across the life cycleEric Youngstrom, Oren Meyers, Jennifer Kogos Youngstrom, et al.
CNS Spectrums|July 14, 2010
A randomized, double-blind, multicenter, parallel-group, placebo-controlled, dose-optimization study of the methylphenidate transdermal system for the treatment of ADHD in adolescentsRobert L Findling, John Turnbow, John Burnside, et al.
Journal of Child and Adolescent Psychopharmacology|June 24, 2014
Efficacy and safety of extended-release quetiapine fumarate in youth with bipolar depression: an 8 week, double-blind, placebo-controlled trialRobert L Findling, Sanjeev Pathak, Willie R Earley, et al.
Biological Psychiatry|October 24, 2006
Comparing the effects of sampling designs on the diagnostic accuracy of eight promising screening algorithms for pediatric bipolar disorderEric Youngstrom, Oren Meyers, Jennifer Kogos Youngstrom, et al.
Paediatric Drugs|April 11, 2018
A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Vilazodone in Adolescents with Major Depressive DisorderSuresh Durgam, Changzheng Chen, Raffaele Migliore, et al.
The American Journal of Psychiatry|August 3, 2002
Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligenceMichael G Aman, Goedele De Smedt, Albert Derivan, et al.
Clinical Neuropharmacology|May 8, 2012
Atomoxetine once daily for 24 weeks in adults with attention-deficit/hyperactivity disorder (ADHD): impact of treatment on family functioningLinda Wietecha, Joel Young, Dustin Ruff, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|July 22, 2005
Pharmacological management of agitation and aggression in an adolescent with autismChristopher J Kratochvil, Robert L Findling, Christopher J McDougle, et al.
Pageof 45